| Trial | Title | Study Record Detail | Phase | Sponsor/Colaborator |
|---|---|---|---|---|
| SGN19A-001 | A Safety Study of SGN-CD19A for B-Cell Lymphoma | NCT01786135 | Phase I | Seattle Genetics, Inc. |
| SGN19A-002 | A Safety Study of SGN-CD19A for Leukemia and Lymphoma | NCT01786096 | Phase I | Seattle Genetics, Inc. |
Last Editorial Review: February 13, 2015
